» Articles » PMID: 32435591

Late-onset Argininosuccinic Aciduria Associated with Hyperammonemia Triggered by Influenza Infection in an Adolescent: A Case Report

Overview
Specialty Endocrinology
Date 2020 May 22
PMID 32435591
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Hyperammonemia is a typical symptom of urea cycle disorders. While early-onset argininosuccinic aciduria (ASA) can often be detected by hyperammonemia, patients with late-onset ASA predominantly present with psychomotor retardation and mental disorders. However, in late-onset ASA that develops during early childhood, hyperammonemia can sometimes be caused by acute infections, stress, and reduced dietary intake. Here, we report the case of a 14-year-old boy with late-onset ASA associated with hyperammonemia that was triggered by an influenza A infection. Due to the infection, he presented with a fever and was unable to eat food or take oral medication. He then experienced restlessness, a disturbance in his level of consciousness, and seizures. Hyperammonemia (3286 μg/dL, reference value ≤100 μg/dL) was detected. He was biochemically diagnosed with ASA based on increased serum and urinary argininosuccinic acid levels. Additionally, genetic testing revealed compound heterozygous mutations in the gene: c.91G > A(p.Asp31Asn) and c.1251-1G > C. This case revealed that in late-onset ASA, hyperammonemia can occur not only in early childhood but also during adolescence. Late-onset ASA may have a very broad clinical spectrum that includes hyperammonemia. We suggest that urea cycle disorders such as ASA must be considered when patients present with hyperammonemic decompensation during adolescence.

Citing Articles

ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model.

Daly O, Mahiny A, Majeski S, McClintock K, Reichert J, Boros G Biomedicines. 2023; 11(6).

PMID: 37371829 PMC: 10296609. DOI: 10.3390/biomedicines11061735.


Late-onset argininosuccinic aciduria in a 72-year-old man presenting with fatal hyperammonemia.

Leuger L, Dieu X, Chao de la Barca J, Moriconi M, Halley G, Donin de Rosiere X JIMD Rep. 2021; 62(1):44-48.

PMID: 34765397 PMC: 8574183. DOI: 10.1002/jmd2.12251.


Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue.

Sen K, Anderson A, Whitehead M, Gropman A Front Neurol. 2021; 12:632307.

PMID: 33995244 PMC: 8113618. DOI: 10.3389/fneur.2021.632307.

References
1.
Trevisson E, Salviati L, Baldoin M, Toldo I, Casarin A, Sacconi S . Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene. Hum Mutat. 2007; 28(7):694-702. DOI: 10.1002/humu.20498. View

2.
Chen B, Ngu L, Zabedah M . Argininosuccinic aciduria: clinical and biochemical phenotype findings in Malaysian children. Malays J Pathol. 2011; 32(2):87-95. View

3.
Baruteau J, Perocheau D, Hanley J, Lorvellec M, Rocha-Ferreira E, Karda R . Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer. Nat Commun. 2018; 9(1):3505. PMC: 6115417. DOI: 10.1038/s41467-018-05972-1. View

4.
Baruteau J, Diez-Fernandez C, Lerner S, Ranucci G, Gissen P, Dionisi-Vici C . Argininosuccinic aciduria: Recent pathophysiological insights and therapeutic prospects. J Inherit Metab Dis. 2019; 42(6):1147-1161. DOI: 10.1002/jimd.12047. View

5.
Batshaw M, Tuchman M, Summar M, Seminara J . A longitudinal study of urea cycle disorders. Mol Genet Metab. 2014; 113(1-2):127-30. PMC: 4178008. DOI: 10.1016/j.ymgme.2014.08.001. View